HIV-1 inhibitor-8

Catalog No. :
ACGFYW889
CAS No. :
2826996-78-3
Molecular Formula :
C25H21N5OS
Molecular Weight :
439.54

IUPAC Name:(E)-4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl)amino)benzonitrile

HIV-1 inhibitor-8 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$207.00Login to see priceInquiryInquiry
5mg98%$452.00Login to see priceInquiryInquiry
10mg98%$678.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameHIV-1 inhibitor-8
IUPAC Name(E)-4-((4-(4-(2-cyanovinyl)-2,6-dimethylphenoxy)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl)amino)benzonitrile
Molecular FormulaC25H21N5OS
Molecular Weight439.54
SMILESN#CC1=CC=C(NC2=NC(OC3=C(C)C=C(/C=C/C#N)C=C3C)=C(CSCC4)C4=N2)C=C1
InChI KeyGLFXFXOZHKJYEL-ONEGZZNKSA-N
SynonymBenzonitrile, 4-[[4-[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenoxy]-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl]amino]-
CAS No.2826996-78-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGFYW889 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFYW889 route product structure diagram
    ACGFYW8892826996-78-3
Inquiry

2. ACGFYW889 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQESY621 route compound structure diagram
    ACQESY6211234662-01-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFYW889 route product structure diagram
    ACGFYW8892826996-78-3
Inquiry

Comments (0)